The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Title |
Evaluating Glycemic Control Efficacy and Safety of the Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron in Type 2 Diabetes Patients: A Systemic Review and Meta-Analysis
|
---|---|
Published in |
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, November 2023
|
DOI | 10.2147/dmso.s439587 |
Pubmed ID | |
Authors |
Hareer Fatima, Hussain Sohail Rangwala, Muhammad Saqlain Mustafa, Muhammad Ashir Shafique, Syed Raza Abbas, Azra Rizwan, Tagwa Kalool Fadlalla Ahmed, Ainan Arshad |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Pakistan | 1 | 50% |
Japan | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 50% |
Members of the public | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 19 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 2 | 11% |
Researcher | 1 | 5% |
Unspecified | 1 | 5% |
Other | 1 | 5% |
Lecturer > Senior Lecturer | 1 | 5% |
Other | 0 | 0% |
Unknown | 13 | 68% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 3 | 16% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 5% |
Unspecified | 1 | 5% |
Neuroscience | 1 | 5% |
Biochemistry, Genetics and Molecular Biology | 1 | 5% |
Other | 0 | 0% |
Unknown | 12 | 63% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 November 2023.
All research outputs
#16,608,224
of 26,180,352 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#518
of 1,207 outputs
Outputs of similar age
#177,276
of 371,423 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#8
of 32 outputs
Altmetric has tracked 26,180,352 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,207 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.2. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 371,423 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.